GlassScriptPhysician profile
Jessica M Wright
NPI 1619249554
$33,287.50
in general payments reported to CMS, 2019-2025
14 companies · $10K in 2025
The $10K reported for 2025 was more than what 99% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,438 · 2022: $6,809 · 2023: $5,465 · 2024: $8,127 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Travel and Lodging: $7,072 · Food and Beverage: $4,900 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,878.00 |
| Travel and Lodging | $7,072.08 |
| Food and Beverage | $4,900.49 |
| Education | $189.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $29,558.99 | 2021-2025 | |
| Harmony Biosciences LLC | $1,460.36 | 2021-2025 | Wakix |
| Axsome Therapeutics, INC. | $906.31 | 2022-2025 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $759.52 | 2023-2025 | Lumryz |
| Inspire Medical Systems, INC. | $318.57 | 2021-2023 | Inspire |
| Ucb, INC. | $94.59 | 2021-2022 | |
| Tris Pharma INC | $45.38 | 2025 | Dyanavel Xr |
| Neos Therapeutics, LP | $35.99 | 2023-2024 | Adzenys Xr-Odt |
| Eisai INC. | $28.08 | 2021 | |
| Convatec INC. | $18.84 | 2022 | |
| Lilly USA, LLC | $18.65 | 2025 | Zepbound |
| Idorsia Pharmaceuticals US INC | $15.70 | 2022 | |
| Resmed Corp | $14.48 | 2024 | |
| Merck Sharp & Dohme LLC | $12.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.